Biotechnology
Biotechnology is gaining market weight. Lost weight for 4 consecutive months.
Most of this industry's gains came from a few companies.
Where did the weight change come from?
12-month contribution in universe percentage points · contributions add to the industry change
The three largest same-direction contributors explain 72% of gross gains. Opposing contributions can make an individual company’s change larger than the industry’s net change.
How has it moved through history?
Share of matched S&P 500 members
Jan 2018 – Feb 2021 · market weight (%)
Relative performance
Industry return versus ACWI · no future data shown
Is participation broad or concentrated?
Actual constituent counts at this date, not the legacy synthetic breadth proxy
This is size concentration, not contribution to the 12-month change. The attribution above measures the latter.
Evidence can disagree
Independent dimensions · no combined score or bullish/bearish verdict
Other evidence and availability
Valuation data: unavailable; shown as zero placeholder.
Attention data: unavailable; shown as zero placeholder.
Actual fund flows: unavailable. No ETF, mutual-fund or institutional flow feed is connected.
Volume / turnover: unavailable in this dataset.
Follow the contribution to individual companies
Sorted by absolute 12-month weight contribution, not investment merit
| Company | Sub-industry | Country | Universe weight | 12M contribution | 12M price return | Revisions |
|---|---|---|---|---|---|---|
| AbbVie → ABBV | Biotechnology | United States | 0.380% | +0.380 pp | +32.4% | 0.0 |
| Amgen → AMGN | Biotechnology | United States | 0.260% | +0.259 pp | +15.8% | 0.0 |
| Gilead Sciences → GILD | Biotechnology | United States | 0.154% | +0.154 pp | -7.9% | 0.0 |
| Vertex Pharmaceuticals → VRTX | Biotechnology | United States | 0.110% | +0.110 pp | -5.1% | 0.0 |
| Regeneron Pharmaceuticals → REGN | Biotechnology | United States | 0.085% | +0.084 pp | +1.3% | 0.0 |
| Biogen → BIIB | Biotechnology | United States | 0.083% | +0.083 pp | -11.5% | 0.0 |
| Incyte → INCY | Biotechnology | United States | 0.035% | +0.034 pp | +4.3% | 0.0 |
Underlying monthly industry observations
| Month | Weight | 1M change | 3M change | 6M change | 12M change | Relative return · 12M |
|---|---|---|---|---|---|---|
| Feb 2021 | 1.107% | -0.267 pp | -1.242 pp | +1.104 pp | +1.105 pp | -15.6% |
| Jan 2021 | 1.374% | -0.891 pp | -1.052 pp | +1.371 pp | -1.006 pp | +0.9% |
| Dec 2020 | 2.265% | -0.084 pp | +2.262 pp | +2.262 pp | -0.288 pp | -7.7% |
| Nov 2020 | 2.349% | -0.077 pp | +2.346 pp | +2.346 pp | -0.272 pp | -7.7% |
| Oct 2020 | 2.426% | +2.423 pp | +2.423 pp | -0.669 pp | -0.055 pp | +2.1% |
| Sep 2020 | 0.003% | -0.000 pp | -0.000 pp | +0.000 pp | -2.317 pp | +18.0% |
| Aug 2020 | 0.003% | +0.000 pp | -0.000 pp | +0.001 pp | -2.360 pp | +18.2% |
| Jul 2020 | 0.003% | -0.000 pp | -3.092 pp | -2.378 pp | -2.270 pp | +29.3% |
| Jun 2020 | 0.003% | -0.000 pp | +0.001 pp | -2.550 pp | -2.400 pp | +34.7% |
| May 2020 | 0.003% | -3.092 pp | +0.001 pp | -2.618 pp | -2.469 pp | +35.3% |
| Apr 2020 | 3.095% | +3.092 pp | +0.714 pp | +0.614 pp | +0.599 pp | +38.6% |
| Mar 2020 | 0.003% | +0.000 pp | -2.550 pp | -2.317 pp | -2.701 pp | +27.5% |
| Feb 2020 | 0.002% | -2.378 pp | -2.619 pp | -2.361 pp | -2.837 pp | +3.7% |
| Jan 2020 | 2.380% | -0.172 pp | -0.101 pp | +0.107 pp | +0.718 pp | -11.5% |
| Dec 2019 | 2.553% | -0.069 pp | +0.233 pp | +0.150 pp | +0.782 pp | -11.5% |
| Nov 2019 | 2.621% | +0.140 pp | +0.259 pp | +0.149 pp | +0.864 pp | -7.6% |
| Oct 2019 | 2.481% | +0.161 pp | +0.208 pp | -0.015 pp | +0.856 pp | -5.9% |
| Sep 2019 | 2.320% | -0.043 pp | -0.083 pp | -0.383 pp | +0.566 pp | -16.7% |
| Aug 2019 | 2.363% | +0.090 pp | -0.110 pp | -0.476 pp | +0.603 pp | -15.0% |
| Jul 2019 | 2.273% | -0.130 pp | -0.223 pp | +0.610 pp | -0.851 pp | -16.3% |
| Jun 2019 | 2.403% | -0.069 pp | -0.300 pp | +0.632 pp | -0.706 pp | -11.3% |
| May 2019 | 2.472% | -0.024 pp | -0.367 pp | +0.715 pp | -0.607 pp | -8.7% |
| Apr 2019 | 2.496% | -0.207 pp | +0.834 pp | +0.871 pp | -0.587 pp | -9.2% |
| Mar 2019 | 2.703% | -0.136 pp | +0.933 pp | +0.949 pp | -0.495 pp | -3.7% |
| Feb 2019 | 2.839% | +1.177 pp | +1.081 pp | +1.080 pp | -0.582 pp | -5.6% |
| Jan 2019 | 1.663% | -0.108 pp | +0.037 pp | -1.462 pp | -1.719 pp | -1.0% |
| Dec 2018 | 1.771% | +0.013 pp | +0.016 pp | -1.339 pp | -1.611 pp | +4.8% |
| Nov 2018 | 1.758% | +0.133 pp | -0.002 pp | -1.321 pp | -1.624 pp | +3.7% |
| Oct 2018 | 1.625% | -0.129 pp | -1.499 pp | -1.459 pp | -1.757 pp | -4.9% |
| Sep 2018 | 1.754% | -0.005 pp | -1.355 pp | -1.444 pp | -1.628 pp | +0.4% |
| Aug 2018 | 1.759% | -1.365 pp | -1.320 pp | -1.662 pp | -1.623 pp | -0.1% |
| Jul 2018 | 3.124% | +0.015 pp | +0.040 pp | -0.258 pp | -0.258 pp | -2.6% |
| Jun 2018 | 3.109% | +0.030 pp | -0.089 pp | -0.273 pp | -0.273 pp | -5.3% |
| May 2018 | 3.079% | -0.005 pp | -0.342 pp | -0.303 pp | -0.303 pp | -6.9% |
| Apr 2018 | 3.084% | -0.114 pp | -0.298 pp | -0.298 pp | -0.298 pp | -7.8% |
| Mar 2018 | 3.198% | -0.224 pp | -0.184 pp | -0.184 pp | -0.184 pp | -6.1% |
| Feb 2018 | 3.421% | +0.039 pp | +0.039 pp | +0.039 pp | +0.039 pp | +1.2% |
| Jan 2018 | 3.382% | +0.000 pp | +0.000 pp | +0.000 pp | +0.000 pp | +0.0% |
How are these descriptive states defined?
Gaining / losing: 12-month weight change above +0.005pp / below −0.005pp. Direction and speed are separate dimensions, not mutually exclusive recommendations.
Accelerating / slowing: compare the most recent 3M change with the preceding 3M change. Accelerating means a positive change speeds up by >0.02pp. Slowing means the magnitude of movement declines by >0.02pp. A falling industry can also slow.
Reversing: the last two 3M changes have opposite signs, outside a ±0.005pp tolerance. Persistence counts consecutive same-direction monthly changes.
Broad / concentrated: company attribution, not a market-cap concentration shortcut. Concentrated means the three largest same-direction contributors account for ≥70% of gross same-direction changes; otherwise broad requires ≥60% of constituents moving with the industry. Other cases are mixed.
Weights use matched S&P 500 members’ market-cap estimates, based on SEC-reported shares available by each month-end and monthly closing prices. Companies without a matched price or share record are omitted, so the denominator is the matched sample rather than every index member. These are not official float-adjusted S&P weights. Flow is not measured.